Doctoral Dissertation

Total Page:16

File Type:pdf, Size:1020Kb

Doctoral Dissertation UNIVERSITY OF CINCINNATI _____________ , 20 _____ I,______________________________________________, hereby submit this as part of the requirements for the degree of: ________________________________________________ in: ________________________________________________ It is entitled: ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ Approved by: ________________________ ________________________ ________________________ ________________________ ________________________ SEXUAL BEHAVIOR CAUSES ACTIVATION AND FUNCTIONAL ALTERATIONS OF MESOLIMBIC SYSTEMS: NEUROBIOLOGY OF MOTIVATION AND REWARD A dissertation submitted to the Division of Research and Advanced Studies of the University of Cincinnati in partial fulfillment of the requirements for the degree of DOCTORATE OF PHILOSOPHY (Ph.D.) in the Graduate Program in Neuroscience of the College of Medicine July 25, 2003 by Margaret E. Balfour B.A. Johns Hopkins University, 1997 Committee Chairs: Lique Coolen, Ph.D. Lei Yu, Ph.D. ABSTRACT There is increasing evidence that the various drugs of abuse converge upon common reward pathways in the brain. While it is clear that these circuits are involved in drug-induced reward and reinforcement, less is known about how these systems function when activated by normal motivated behaviors such as sexual behavior. Like drugs of abuse, sexual behavior is a rewarding and reinforcing behavior. Sexual behavior, however, is generally not considered an “addictive” behavior. Thus, understanding how neural circuits are activated by normal motivated behaviors may lead to a better understanding of the pathology of drug addiction. The first set of studies investigated the mechanisms by which sexual behavior activates the mesolimbic dopamine (DA) system – a critical component of the neural circuitry regulating motivation and reward. These studies found that both sexual experience and sex-associated environmental cues cause endogenous opioid release and activation of DA producing neurons in the ventral tegmental area (VTA). In addition, a large population of non-dopaminergic neurons was activated by sexual behavior. Therefore, the second set of studies explored the anatomical relationship between these sex-activation neurons and other components of the limbic system. These studies suggest that the medial prefrontal cortex (mPFC) may contribute to the activation of this cell population. The final set of studies investigated whether repeated endogenous activation of the mesolimbic system causes similar functional changes as repeated administration of drugs of abuse. Indeed, sexually experienced animals displayed a robust sensitization to the locomotor effects of amphetamine. Taken together, these studies suggest that sexual behavior activates the mesolimbic DA pathway and that repeated endogenous activation of this system results in long-term changes in its function. ACKNOWLEDGEMENTS I would like to thank the following: My parents Jimmy and Ellen and my brother Jay, for your love and support through the years, and my fiancé Adam, for your love and support in the years to come. My thesis advisors: Dr. Lique Coolen, for being a both a great friend and advisor, and Dr. Lei Yu, for always being there for me. My thesis committee: Dr. Lique Coolen, Dr. Lei Yu, Dr. Gary Gudelsky, Dr. Neil Richtand, and Dr. Frank Sharp, for your advice and encouragement. The members of the Coolen and Yu labs, past and present, for all of your much appreciated help with this project, and for creating a wonderful environment in which to work, and my fellow students in the Neuroscience Program and PSTP. The Neuroscience Graduate Program, especially Dr. Mike Lehman and Deb Cummins, and the Physician Scientist Training Program, especially Terri Berning, Dr. Les Myatt and Dr. Judy Harmony. The National Institute on Drug Abuse and the PSTP Anonymous Donor, for your financial support of this work. TABLE OF CONTENTS List of Tables ii List of Illustrations iii List of Abbreviations vi Chapter 1: General Introduction 1 References 18 Figures 23 Chapter 2: Sexual behavior and sex-associated environmental cues activate the 25 mesolimbic system in male rats Introduction 26 Methods 28 Results 34 Discussion 38 References 45 Tables 48 Figures 54 Chapter 3: Anatomical relationship between medial prefrontal cortex and 61 nucleus accumbens efferents and sex-activated neurons Introduction 62 Methods 64 Results 73 Discussion 79 References 85 Figures 87 Chapter 4: Sexual behavior causes a sensitized locomotor response to 98 amphetamine in male rats Introduction 99 Methods 101 Results 109 Discussion 119 References 126 Figures 129 Chapter 5: General Discussion 139 References 151 Figures 161 i LIST OF TABLES Chapter 2 Table 1. Summary of sexual behavior during the final pre-test mating session 48 Table 2. Summary of sexual behavior on the test day 49 Table 3. Percentages of TH cells expressing Fos 50 Table 4. Fos expression in non-dopaminergic neurons 51 Table 5a. Fos expression in NAc Core 52 Table 5b. Fos expression in NAc Shell 53 ii LIST OF ILLUSTRATIONS Chapter 1 Figure 1. Schematic diagram of the circuitry involved in motivation and reward. 23 Figure 2. Schematic diagram illustrating the mechanism by which opioid action 24 in the VTA stimulates DA release in the NAc. Chapter 2 Figure 1. Schematic drawings illustrating the areas of analysis of Fos/TH-IR, 54 indicated by the boxes, in the VTA at four rostral to caudal levels. Figure 2. Schematic drawings illustrating the areas of analysis (indicated by the 55 boxes; 400 µm x 600 µm) of Fos-IR in the NAc Core and Shell at three rostral to caudal levels Figure 3. Color plate 56 Figure 4. MOR internalization in VTA neurons. A, Numbers of MOR-IR 57 endosome-like particles per cell. Figure 5. Percentage of TH-IR cells that are Fos-IR in the VTA 58 Figure 6. Numbers of nondopaminergic cells that are Fos-IR in the VTA 59 Figure 7. Numbers of Fos-IR cells in the NAc. Mean numbers ± SEM of Fos-IR 60 cells in the NAc Core (A) or NAc Shell (B) averaged over three rostral-to-caudal levels. Chapter 3 Figure 1. Schematic diagram illustrating areas of analysis for Fos/BDA/NeuN 87 counts in the NAc Core and Shell at three rostrocaudal levels (A-C), BST (D), BLA (E), VTA at four rostrocaudal levels (F-I) and SPFp (G). Figure 2. Color plate 88 Figure 3. Schematic illustration of location and sizes of injections sites 89 Figure 4. Camera lucida drawings illustrating the distribution of fibers projecting 90 from the ILA, PL and ACA to four rostrocaudal levels of the VTA iii Figure 5. Camera lucida drawings illustrating the distribution of fibers projecting 91 from the ILA, PL and ACA to three rostrocaudal levels of the NAc Figure 6. Camera lucida drawings illustrating the distribution of fibers projecting 92 from the ILA, PL and ACA to the MPN, BST, and MEA Figure 7. Camera lucida drawings illustrating the distribution of fibers projecting 93 from the NAc Shell to four rostrocaudal levels of the VTA Figure 8. Camera lucida drawings illustrating the distribution of fibers projecting 94 from the NAc Core to four rostrocaudal levels of the VTA Figure 9. Camera lucida drawings illustrating the distribution of fibers projecting 95 from the NAc Core and Shell to the MPN Figure 10. Quantification of the relative contribution of the mPFC and NAc to 96 sex-induced activation of VTA neurons Figure 11. Quantification of the relative contribution of ILA and PL to sex- 97 induced activation of neurons in other areas related to sexual behavior and motivation Chapter 4 Figure 1. Schematic diagram of the zone map used to measure locomotor activity 129 Figure 2. Schematic drawings illustrating the areas of analysis of Fos/TH-IR, 130 indicated by the boxes, in the PFC, NAc, and VTA Figure 3. Experiment 1: Locomotor response of sexually experienced and naïve 131 animals in response to saline or amphetamine administered in a novel environment Figure 4. Experiment 2: Locomotor response of sexually experienced and naïve 132 animals in response to saline or amphetamine administered in a novel or non- novel environment Figure 5. Experiment 3: Locomotor response to the mating environment 133 Figure 6. Experiment 3: Locomotor response of sexually experienced and naïve 134 animals in response to saline or amphetamine administered in the same environment in which they received sexual experience, one day following the final pre-test mating session (Day 8). iv Figure 7. Experiment 3: Locomotor response of sexually experienced and naïve 135 animals in response to saline or amphetamine administered in the same environment in which they received sexual experience, one week following the final pre-test mating session (Day 14) Figure 8. Experiment 3: Locomotor response of sexually experienced and naïve 136 animals in response to saline or amphetamine administered in the same environment in which they received sexual experience, one month following the final pre-test mating session (Day 35). Figure 9. Experiment 1: Numbers of Fos-IR cells in the NAc of sexually 137 experienced and naïve animals in response to saline or amphetamine administered in a novel environment Figure 10. Experiment 1: Numbers of Fos-IR cells in the VTA of sexually 138 experienced and naïve animals in response to saline or amphetamine administered in a novel environment Chapter 5 Figure 1. Proposed circuitry model 161 v LIST OF ABBREVIATIONS AAA: Anterior Amygdaloid Area ACAd: Anterior Cingulate
Recommended publications
  • Addiction, Opioids, and Beyond
    Addiction, Opioids and Beyond Chronic Pain Mental Illness Substance Dep Medical Illness Genetics/Env Objectives Understanding Definitions in Substance Dependency and Addiction. Review of Basic Epidemiology in Opioids Understanding Basic Addiction Physiology and how it relates to Schizophrenia Knowledge the General Overview of SUD Treatment Knowledge of non-pharmacological treatments of SUD. Understanding of Prescription Opioids, Side Effects and Dangers Understanding Prescription Opioids in the setting of Chronic Pain Understand MAT for Opioids (Tip43) with Naltrexone, Methadone and Buprenorphine Naloxone WHAT DOES ADDICTION MEAN? In 2016 11.5 million people 12 years and older misused opioid pain medications 1.8 million had substance use disorder involving prescription pain medications Between 2000 to 2015, more then 500,000 person died from opioid overdoses Opioid and 2012 clinicians wrote 259 million prescription for opioids Overdose 2.5 million people with Opioid Addiction (JAMA) US deaths from drug overdoses hit record high in 2014, propelled by abuse of prescription painkillers and heroin. (CDC) Heroin related deaths tripled since 2010. Only 2.2% of US Physician have waiver to prescribe Buprenorphine (JAMA) Statistically, nonmedical use of drugs from individuals obtained a majority of their drugs from friends and relatives, however 80% of those “friends and family” obtained from ONE DOCTOR. Addiction Poorly Understood • Regard Addiction as a moral problem • Fail to adequately screen • 1% of medical school curriculum • Believe interventions are ineffective JAMA,2003,290, 1299 Defining the Word "Addiction" The American Society of Addiction Medicine (ASAM), American Pain Society (APS), and American Academy of Pain Medicine (AAPM) define addiction as a primary, chronic, neurobiological disease with genetic, psychosocial, and environmental factors influencing its development and manifestations characterized by one or more of the behaviors listed above (ASAM, 2001).
    [Show full text]
  • Neuroplasticity in the Mesolimbic System Induced by Sexual Experience and Subsequent Reward Abstinence
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 6-21-2012 12:00 AM Neuroplasticity in the Mesolimbic System Induced by Sexual Experience and Subsequent Reward Abstinence Kyle Pitchers The University of Western Ontario Supervisor Lique M. Coolen The University of Western Ontario Graduate Program in Anatomy and Cell Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Kyle Pitchers 2012 Follow this and additional works at: https://ir.lib.uwo.ca/etd Recommended Citation Pitchers, Kyle, "Neuroplasticity in the Mesolimbic System Induced by Sexual Experience and Subsequent Reward Abstinence" (2012). Electronic Thesis and Dissertation Repository. 592. https://ir.lib.uwo.ca/etd/592 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. NEUROPLASTICITY IN THE MESOLIMBIC SYSTEM INDUCED BY SEXUAL EXPERIENCE AND SUBSEQUENT REWARD ABSTINENCE (Spine Title: Sex, Drugs and Neuroplasticity) (Thesis Format: Integrated Article) By Kyle Kevin Pitchers Graduate Program in Anatomy and Cell Biology A thesis submitted in partial fulfillment of the requirements for degree of Doctor of Philosophy The School of Graduate and Postdoctoral Studies The University of Western Ontario London, Ontario, Canada © Kyle K. Pitchers, 2012 THE UNIVERSITY
    [Show full text]
  • The Effects of Alcohol and Nicotine Pretreatment During Adolescence on Adulthood Responsivity to Alcohol Antoniette M
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School 2007 The effects of alcohol and nicotine pretreatment during adolescence on adulthood responsivity to alcohol Antoniette M. Maldonado University of South Florida Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the American Studies Commons Scholar Commons Citation Maldonado, Antoniette M., "The effects of alcohol and nicotine pretreatment during adolescence on adulthood responsivity to alcohol" (2007). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/2272 This Thesis is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. The Effects of Alcohol and Nicotine Pretreatment During Adolescence on Adulthood Responsivity to Alcohol by Antoniette M. Maldonado A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Arts Department of Psychology College of Arts and Sciences University of South Florida Major Professor: Cheryl L. Kirstein, Ph.D. Mark Goldman, Ph.D. Toru Shimizu, Ph.D. David J. Drobes, Ph.D. Date of Approval: 18 October, 2007 Keywords: addiction, adolescent, alcohol-nicotine interactions, conditioned place preference, novelty preference © Copyright 2007, Antoniette M. Maldonado Dedication To my mom, Sylvia Ann Valdez. Mom, you are my very best friend and I do not know what I would have done without all of the support you gave me through every single step of this journey. You make such a difference in my life and I cannot even begin to describe how grateful I am to have you still here with me.
    [Show full text]
  • Ventral Tegmental Area Dopamine Cell Activation During Male Rat
    The Journal of Neuroscience, September 21, 2016 • 36(38):9949–9961 • 9949 Behavioral/Cognitive Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and D-Amphetamine Cross-Sensitization following Sex Abstinence Lauren N. Beloate,1,2 XAzar Omrani,4 Roger A. Adan,4 Ian C. Webb,1 and XLique M. Coolen1,3 1Department of Neurobiology and Anatomical Sciences, 2Graduate Program in Neuroscience, and 3Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi 39216, and 4Brain Center Rudolf Magnus, Department of Translational Neuroscience, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands Experience with sexual behavior causes cross-sensitization of amphetamine reward, an effect dependent on a period of sexual reward abstinence. We previously showed that ⌬FosB in the nucleus accumbens (NAc) is a key mediator of this cross-sensitization, potentially via dopamine receptor activation. However, the role of mesolimbic dopamine for sexual behavior or cross-sensitization between natural and drug reward is unknown. This was tested using inhibitory designer receptors exclusively activated by designer drugs in ventral tegmental area (VTA) dopamine cells. rAAV5/hSvn-DIO-hm4D-mCherry was injected into the VTA of TH::Cre adult male rats. Males received clozapine N-oxide (CNO) or vehicle injections before each of 5 consecutive days of mating or handling. Following an abstinence period of 7 d, males were tested for amphetamine conditioned place preference (CPP). Next, males were injected with CNO or vehicle before mating or handling for analysis of mating-induced cFos, sex experience-induced ⌬FosB, and reduction of VTA dopamine soma size. Results showed that CNO did not affect mating behavior.
    [Show full text]
  • The Role of Mesolimbic Reward Neurocircuitry in Prevention and Rescue of the Activity-Based Anorexia (ABA) Phenotype in Rats
    Neuropsychopharmacology (2017) 42, 2292–2300 © 2017 American College of Neuropsychopharmacology. All rights reserved 0893-133X/17 www.neuropsychopharmacology.org The Role of Mesolimbic Reward Neurocircuitry in Prevention and Rescue of the Activity-Based Anorexia (ABA) Phenotype in Rats 1 1 ,1 Claire J Foldi , Laura K Milton and Brian J Oldfield* 1 Department of Physiology, Monash University, Clayton, VIC, Australia Patients suffering from anorexia nervosa (AN) become anhedonic; unable or unwilling to derive normal pleasures and avoid rewarding outcomes, most profoundly in food intake. The activity-based anorexia (ABA) model recapitulates many of the characteristics of the human condition, including anhedonia, and allows investigation of the underlying neurobiology of AN. The potential for increased neuronal activity in reward/hedonic circuits to prevent and rescue weight loss is investigated in this model. The mesolimbic pathway extending from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) was activated using a dual viral strategy, involving retrograde transport of Cre (CAV-2-Cre) to the VTA and coincident injection of DREADD receptors (AAV-hSyn-DIO-hM3D(Gq)-mCherry). Systemic clozapine-n-oxide (CNO; 0.3 mg/kg) successfully recruited a large proportion of the VTA-NAc dopaminergic projections, with activity evidenced by colocalization with elevated levels of Fos protein. The effects of reward circuit activation on energy balance and predicted survival was investigated in female Sprague-Dawley rats, where free access to running wheels was paired with time-limited (90 min) access to food, a paradigm (ABA) which will cause anorexia and death if unchecked. Excitation of the reward pathway substantially increased food intake and food anticipatory activity (FAA) to prevent ABA-associated weight loss, while overall locomotor activity was unchanged.
    [Show full text]
  • Early Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders
    Brain Sci. 2015, 5, 258-274; doi:10.3390/brainsci5030258 OPEN ACCESS brain sciences ISSN 2076-3425 www.mdpi.com/journal/brainsci/ Review Early Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders Joan Y. Holgate * and Selena E. Bartlett Institute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology, 37 Kent St, Woolloongabba, Queensland 4102, Australia; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +61-7-3443-7285; Fax: +61-7-3443-7779. Academic Editor: Marcelo Febo Received: 15 April 2015 / Accepted: 18 June 2015 / Published: 30 June 2015 Abstract: Stress is a major driving force in alcohol use disorders (AUDs). It influences how much one consumes, craving intensity and whether an abstinent individual will return to harmful alcohol consumption. We are most vulnerable to the effects of stress during early development, and exposure to multiple traumatic early life events dramatically increases the risk for AUDs. However, not everyone exposed to early life stress will develop an AUD. The mechanisms determining whether an individual’s brain adapts and becomes resilient to the effects of stress or succumbs and is unable to cope with stress remain elusive. Emerging evidence suggests that neuroplastic changes in the nucleus accumbens (NAc) following early life stress underlie the development of AUDs. This review discusses the impact of early life stress on NAc structure and function, how these changes affect cholinergic signaling within the mesolimbic reward pathway and the role nicotinic acetylcholine receptors (nAChRs) play in this process.
    [Show full text]
  • Volatile Solvents As Drugs of Abuse: Focus on the Cortico-Mesolimbic Circuitry
    Neuropsychopharmacology (2013) 38, 2555–2567 & 2013 American College of Neuropsychopharmacology. All rights reserved 0893-133X/13 www.neuropsychopharmacology.org Review Volatile Solvents as Drugs of Abuse: Focus on the Cortico-Mesolimbic Circuitry 1,2 ,1,2 Jacob T Beckley and John J Woodward* 1 2 Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA; Center for Drug and Alcohol Programs, Department of Psychiatry/Neurosciences, Medical University of South Carolina, Charleston, SC, USA Volatile solvents such as those found in fuels, paints, and thinners are found throughout the world and are used in a variety of industrial applications. However, these compounds are also often intentionally inhaled at high concentrations to produce intoxication. While solvent use has been recognized as a potential drug problem for many years, research on the sites and mechanisms of action of these compounds lags behind that of other drugs of abuse. In this review, we first discuss the epidemiology of voluntary solvent use throughout the world and then consider what is known about their basic pharmacology and how this may explain their use as drugs of abuse. We next present data from preclinical and clinical studies indicating that these substances induce common addiction sequelae such as dependence, withdrawal, and cognitive impairments. We describe how toluene, the most commonly studied psychoactive volatile solvent, alters synaptic transmission in key brain circuits such as the mesolimbic dopamine system and medial prefrontal cortex (mPFC) that are thought to underlie addiction pathology. Finally, we make the case that activity in mPFC circuits is a critical regulator of the mesolimbic dopamine system’s ability to respond to volatile solvents like toluene.
    [Show full text]
  • Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age
    The Journal of Neuroscience, December 5, 2007 • 27(49):13371–13375 • 13371 Brief Communications Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age Monika Cs. Horvath,1 Gabor G. Kovacs,2 Viktor Kovari,2 Katalin Majtenyi,2 Yasmin L. Hurd,3* and Eva Keller1* 1Department of Forensic Medicine, Semmelweis University, H-1085, Budapest, Hungary, 2National Institute of Psychiatry and Neurology, H-1021, Budapest, Hungary, and 3Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029 Dysfunction of mesocorticolimbic dopaminergic neurons is considered a common feature of all drugs of abuse, yet few investigations have evaluated the dopamine (DA) system in nonstimulant human abusers. We examined mRNA expression levels of DA transporter ␣ (DAT), tyrosine hydroxylase (TH), dopamine D2 receptor, -synuclein, and nuclear receptor-related 1 (Nurr1) in discrete mesocorti- colimbic and nigrostriatal subpopulations of heroin users and control subjects. The chronic use of heroin was significantly associated with decreased DAT mRNA expression localized to the paranigral nucleus (PN) and the mesolimbic division of the ventral tegmental area (VTA) with no alterations in nigrostriatal populations. Consistently, the density of DAT immunoreactivity was significantly reduced in the nucleus accumbens but not in dorsal striatum, mesolimbic and nigrostriatal efferent targets, respectively. Significant alteration of the mRNA expression of Nurr1, a transcription factor that regulates DAT expression, was also confined to the PN. Moreover, the results revealed an exaggerated reduction of Nurr1 expression with age in heroin users (r ϭϪ0.8268, p Ͻ 0.001 vs controls, r ϭϪ0.6204, p ϭ ␣ 0.0746).
    [Show full text]
  • Non-Pharmacological Factors That Determine Drug Use and Addiction Aldo Badiani, Klaus Miczek, Christian Müller, Serge Ahmed H
    Non-pharmacological factors that determine drug use and addiction Aldo Badiani, Klaus Miczek, Christian Müller, Serge Ahmed H. To cite this version: Aldo Badiani, Klaus Miczek, Christian Müller, Serge Ahmed H.. Non-pharmacological factors that determine drug use and addiction. Neuroscience & Biobehavioral Reviews, Oxford: Elsevier Ltd., 2020, 110, pp.3-27. 10.1016/j.neubiorev.2018.08.015. hal-03005497 HAL Id: hal-03005497 https://hal.archives-ouvertes.fr/hal-03005497 Submitted on 25 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Special Issue – IBNS Non-pharmacological factors that determine drug use and addiction Serge Ahmed 1*, Aldo Badiani 2,3*, Klaus A. Miczek 4,5*, Christian P. Müller 6* 1 Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 146 rue Léo-Saignat, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 146 rue Léo-Saignat, F-33000 Bordeaux, France. 2 Department of Physiology and Pharmacology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy. 3 Sussex Addiction Research and Intervention Centre (SARIC), School of Psychology, University of Sussex, BN1 9RH, Brighton, UK. 4 Psychology Department, Tufts University, Bacon Hall, 530 Boston Avenue, Medford, MA, 02155, USA.
    [Show full text]
  • Neurobiological Basis of Vulnerability in Adolescence to Drug
    REVIEW ARTICLE Neurobiological Basis of Vulnerability in Adolescence to Drug Use SUNITA MANCHANDA1 From 1Max Hospital Gurugram, Haryana Correspondence to: Dr Sunita Manchanda, Max Hospital, Gurugram,122001, Haryana, India [email protected] In adolescence, there is heightened susceptibility to drugs. Neurobiology of addiction is based on the working of four neural networks: (a) reward (b) memory and learning (c) motivation/drive (d) control. Knowledge of neurobiological vulnerabilities is essential for prevention and treatment interventions. Key words : Substance abuse, Neurobiological basis, Drug addiction Adolescence is a critical period of life in which the developing [4]. The progression from initial drug use to addiction may brain is highly vulnerable to the impact of life experiences. It is involve repeated activation of the mesolimbic pathway which also a time of heightened susceptibility to the effects of addictive increases the motivational salience (a form of attention that drugs.Various factors have been associated with increased risk of motivates toward a behavior) of the drug. As contextual cues substance use during this period. Epidemiological evidence become associated and strengthened with repetitive drug suggests that substance use disorders (SUDs) are more likely to administration, a process initially under the purview of the develop in people who begin experimenting with drugs early mesolimbic dopaminergic system progressively incorporates the during their adolescence, but this correlation does not guarantee neurocircuitory involved in emotional, memory, obsessive causation.The neurobiological mechanisms underlying thoughts, stress response, decision making, and behavioral vulnerability to drug addiction are poorly understood and are inhibition, into the drug experience [4]. Even in the absence of likely to involve a balance between factors that confer ongoing drug use these neuro-adaptive responses remain vulnerability and those that protect against it.
    [Show full text]
  • Pharmacology - the Reward Pathway
    Pharmacology - The reward pathway All drugs of abuse and dependence share one thing in common. They increase the activity of a neurotransmitter called dopamine in the reward pathway of the brain. Activating this reward pathway, which crosses the limbic region of the brain and connects with the cortex-- that is, it crosses the emotional centre of the brain and connects to the decision-making part of the brain-- will reinforce a behaviour. It does so because it produces a pleasurable feeling. Dopamine is a monoamine. Our mood is affected by the monoamines. There's an association between the altered function of monoamine neurotransmitters such as dopamine in the brain, and disorders such as depression and anxiety. Indeed, drugs that increase the amount of these neurotransmitters are the major medical approach to treating disorders such as depression. Dopamine pathways commence in the brainstem, and project diffusely to the cortex. So that is, they're taking us through parts of the brain associated with feelings, and thoughts, and cognition, and memory, and movement. So dopamine is important in the control of mood and emotion, thought patterns, and the laying down of memories. It's also important in the control of sleep, feeding behaviour, and the control of body temperature. Dopamine is the fuel for intentional behaviours. And it's the fuel for desire. Dopamine says, I want and I desire. Dopamine production is turned on when we're cued by a stimulus paired with a reward, when we're doing something that is good for our survival. For this lecture, there are three main dopamine pathways that we're most interested in.
    [Show full text]
  • Opioid Use Disorder Concepts in Medical Management
    Opioid Use Disorder Concepts in Medical Management Deborah Rose, MD American Board of Preventive Medicine, Addiction Medicine American Board of Integrative Medicine American Board of Surgery During this part of the discussion: • Concepts defining substance use disorders • Types of opioid medications and the pharmacologic properties that define them • Medications used to treat opioid use disorder WHY Do We Use Medication?? • During withdrawal and protracted abstinence, patients have increased sensitivity to pain, a frequent trigger of relapse. • Overexpression of transcription factors which increase sensitivity to rewarding effects of drugs which remain for weeks-months after drug use • Opioid receptor desensitization & internalization • Because, for most people, abstinence-based recovery does not work for OUDs with failure rates 80-90% or more. Multiple factors. • Increased stress response activation • Decreased reward system activation American Society of Addiction Medicine Definition of Addiction Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leas to characteristic biological, psychological, social and spiritual manifestations. ASAM Definition of Addiction (cont’d) This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors. Addiction is characterized by inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with one’s behaviors
    [Show full text]